Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues
申请人:Chen Genhui
公开号:US20080139666A1
公开(公告)日:2008-06-12
The present invention provides novel methods of treating psoriasis, protein tyrosine kinase-associated disorders, inflammation, epidermal hyperproliferation, diabetes, immune and autoimmune diseases, eczema, and inflammatory bowel disease, inhibiting protein kinase, neutrophil activation, cell proliferation, tumour growth, metastasis, and the development of atheromatous plaque and restonosis, controlling angiogenesis, and preventing inflammatory bowel disease, using hydroxystilbenes and novel stilbene derivatives.
本发明提供了使用羟基苯乙烯和新型苯乙烯衍生物的治疗方法,包括治疗银屑病、蛋白酪氨酸激酶相关疾病、炎症、表皮细胞过度增殖、糖尿病、免疫和自身免疫疾病、湿疹、炎性肠病,抑制蛋白激酶、中性粒细胞激活、细胞增殖、肿瘤生长、转移和动脉粥样硬化斑块和再狭窄的发展,控制血管生成,预防炎症性肠病。